Men's multivitamins recalled due to undeclared allergen: FDA

Fox News - Apr 15th, 2025

MTN OPS LLC, a Utah-based company, has initiated a recall of its Multi-V Men multivitamins due to the presence of an undeclared allergen, soy flour, which could pose a serious risk to consumers with soy allergies. The recall, affecting 7,546 bottles, was classified by the FDA as Class II, indicating that the product may cause temporary or medically reversible adverse health consequences. These multivitamins, designed to support men's daily and immune health, contain essential nutrients like calcium, zinc, and vitamin C. However, they may prove deadly to those with soy allergies if consumed.

This recall highlights the ongoing challenges in ensuring the safety of over-the-counter supplements, as recalls in this sector, while uncommon, do occur. The significance of this recall lies in its potential implications for consumer trust and the regulatory oversight of dietary supplements. It underscores the importance of accurate labeling and ingredient disclosure, especially for products meant to enhance health. The incident also raises questions about the quality control processes in place at supplement manufacturers and the FDA's role in safeguarding public health. Fox News Digital reached out to MTN OPS for further comment but did not receive an immediate response.

Fda Mtn Ops Llc Multivitamin Recall Soy Allergen Health And Safety Dietary Supplements

Story submitted by Fairstory

RATING

8.2

Fair Story

Consider it well-founded

The article provides a clear and accurate account of a multivitamin recall due to an undeclared allergen, with detailed information on the product and its potential health risks. It is timely and relevant, addressing a public health concern that affects consumers directly. The story's main strength lies in its factual accuracy and clarity, making it accessible to a general audience. However, the article could benefit from greater balance and engagement by including expert opinions or broader industry context. While it effectively informs readers about the recall, it lacks the depth and perspective needed to drive meaningful discussion or policy change. Overall, the article is a reliable source of information but could be enhanced by incorporating diverse viewpoints and additional context.

Accuracy

The story is factually accurate regarding the recall of MTN OPS LLC's men's multivitamins due to an undeclared allergen, soy flour. It correctly identifies the number of bottles affected, the lot number, and the expiration date, matching details from official sources such as the FDA and other recall databases. However, the story could improve by providing more context on the health risks associated with soy allergies, which are mentioned but not elaborated upon. The classification of the recall as Class II by the FDA is also accurately reported, indicating the potential health consequences are not severe but could still pose risks to certain individuals.

Balance

The article primarily focuses on the recall details and the potential health risks for consumers with soy allergies. While it provides a thorough account of the recall, it lacks a broader perspective on how such recalls impact consumer trust and industry practices. Including viewpoints from health experts or consumer safety advocates could have enriched the narrative, offering readers a more comprehensive understanding of the implications of such recalls.

Clarity

The article is well-structured and uses clear, concise language to convey the recall information. It logically presents the facts, starting with the recall's announcement and moving through the details of the affected products. The use of bullet points or lists could have further improved readability, but overall, the article is easy to understand and effectively communicates the essential information.

Source quality

The article references credible sources such as the FDA, which lends authority to the recall information. However, it primarily relies on a single company, MTN OPS LLC, for product details and does not include commentary from independent health experts or consumer safety organizations. This reliance on limited sources could affect the depth of the analysis and the perceived impartiality of the report.

Transparency

The article is transparent in disclosing the recall's basis and the FDA classification. However, it lacks transparency regarding the methodology used to gather information. The article does not detail how the information was verified or whether any conflicts of interest might exist. Greater transparency about how the story was developed and the challenges in obtaining company comments would enhance the article's credibility.